Disease-specific mechanisms of gene variants causing schwannomatosis versus other rare conditions

This federal Project Grant award of $523,614.37, provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program, supports advanced biomedical research into the genetic mechanisms underlying schwannomatosis and other rare conditions. The University of Manchester, a prominent research institution in the United Kingdom, will conduct this 3-year research initiative, focusing on elucidating the disease-specific genetic factors that distinguish schwannomatosis from similar rare disorders. Through this award, the University of Manchester will leverage its expertise in areas such as materials science, biomedical research, and genetic analysis to advance scientific understanding and support national security and public health objectives. The research project aligns with the Military Medical Research and Development program's focus on transforming healthcare for military service members and the broader public through innovative, impactful biomedical research.